Evidence map›Paper›PMID 31040355›Full record

ArticleScientific reports2019

An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species.

Tesfaye Rufael Chibssa, Tirumala Bharani K Settypalli, Francisco J Berguido, Reingard Grabherr, Angelika Loitsch, Eeva Tuppurainen, Nick Nwankpa, Karim Tounkara, Hafsa Madani, Amel Omani and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 6 countries.

Tesfaye Rufael ChibssaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 100, A1400, Vienna, Austria.
Tirumala Bharani K SettypalliAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 100, A1400, Vienna, Austria.ORCID http://orcid.org/0000-0002-9090-8471
Francisco J BerguidoAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 100, A1400, Vienna, Austria.
Reingard GrabherrInstitute of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Muthgasse 18, 1190, Vienna, Austria.
Angelika LoitschInstitute for Veterinary Disease Control, Austrian Agency for Health and Food Safety (AGES), Mödling, Austria.
Eeva TuppurainenIndependent veterinary consultant, Helsinki, Finland.
Nick NwankpaAfrican Union Pan African Veterinary Vaccine Centre, (AU-PANVAC), P.O. Box 1746, Debre Ziet, Ethiopia.
Karim TounkaraAfrican Union Pan African Veterinary Vaccine Centre, (AU-PANVAC), P.O. Box 1746, Debre Ziet, Ethiopia.
Hafsa MadaniInstitut National de la Médecine Vétérinaire, Laboratoire Central Vétérinaire d'Alger, Algiers, Algeria.
Amel OmaniInstitut National de la Médecine Vétérinaire, Laboratoire Central Vétérinaire d'Alger, Algiers, Algeria.
Mariane DiopLaboratoire National d'Elevage et de Recherches Vétérinaires, Institut Sénégalais de Recherches Agricoles (ISRA), BP 2057 Dakar-Hann, Dakar, Senegal.
Giovanni CattoliAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 100, A1400, Vienna, Austria.
Adama DialloLaboratoire National d'Elevage et de Recherches Vétérinaires, Institut Sénégalais de Recherches Agricoles (ISRA), BP 2057 Dakar-Hann, Dakar, Senegal.
Charles Euloge LamienAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 100, A1400, Vienna, Austria. C.Lamien@iaea.org.ORCID http://orcid.org/0000-0003-1899-7614
International Atomic Energy Agency · ATAfrican Union · ETHigher National Veterinary School · DZAustrian Agency for Health and Food Safety · ATBOKU University · ATCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRInstitut Sénégalais de Recherches Agricoles · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sheep poxvirus (SPPV), goat poxvirus (GTPV) and lumpy skin disease virus (LSDV) affect small ruminants and cattle causing sheeppox (SPP), goatpox (GTP) and lumpy skin disease (LSD) respectively. In endemic areas, vaccination with live attenuated vaccines derived from SPPV, GTPV or LSDV provides protection from SPP and GTP. As live poxviruses may cause adverse reactions in vaccinated animals, it is imperative to develop new diagnostic tools for the differentiation of SPPV field strains from attenuated vaccine strains. Within the capripoxvirus (CaPV) homolog of the variola virus B22R gene, we identified a unique region in SPPV vaccines with two deletions of 21 and 27 nucleotides and developed a High-Resolution Melting (HRM)-based assay. The HRM assay produces four distinct melting peaks, enabling the differentiation between SPPV vaccines, SPPV field isolates, GTPV and LSDV. This HRM assay is sensitive, specific, and provides a cost-effective means for the detection and classification of CaPVs and the differentiation of SPPV vaccines from SPPV field isolates.

Indexed as

Real-Time Polymerase Chain ReactionAnimalsCapripoxvirusDNA, ViralPhylogenyReproducibility of ResultsSensitivity and SpecificitySequence Analysis, DNASheepSheep DiseasesTransition TemperatureViral VaccinesDNA, ViralViral Vaccines

Identifiers

PMID31040355
PMCPMC6491823
OpenAlexW2943171564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.